Results 161 to 170 of about 24,256 (259)

Circulating metabolites mediating the effect of psoriatic arthritis on Crohn disease risk: A mediation Mendelian randomization study. [PDF]

Medicine (Baltimore)
Qin X, Deng J, Chen B, Tan X, Xie X, Zhou G, Hou W, Wen S, Lin Y.   +8 more
europepmc   +1 more source

Efficacy and Safety of Cannabis Derivates and Their Synthetic Analogs. Overview of Systematic Reviews

Phytotherapy Research, EarlyView.
ABSTRACT The use of medicinal products derived from cannabis and its synthetic analogues has grown in recent years for various health conditions, which led to an increase in systematic reviews (SR) on the topic. The objective of this overview was to identify, synthesize, and critically appraise the evidence from SR on the benefits and harms of cannabis
Rafael Leite Pacheco, Daniela Fortunato Rêgo, Carolina de Oliveira Cruz Latorraca, Marco Aurelio de Carvalho Nascimento, André Bastos Daher, Rachel Riera   +5 more
wiley   +1 more source

Correction to: Characterization of mesocolic adipose hyperplasia in a rat 2,4,6-trinitrobenzenesulfonic acid colitis model and comparison to creeping fat in Crohn disease. [PDF]

Inflamm Bowel Dis
europepmc   +1 more source

Long-term risk factors of stoma construction after loose seton placement for Crohn disease-associated perianal fistulas. [PDF]

Ann Coloproctol
Nakao E, Tatsumi K, Obara N, Goto K, Kuroki H, Sugita A, Koganei K.   +6 more
europepmc   +1 more source

Pink Polypoid Papulo‐Vesicles on Labia Majora

JEADV Clinical Practice, EarlyView.
Maria Chiara Mercuri, Michela Tabanelli, Silvia Zago, Diego Abbenante   +3 more
wiley   +1 more source

Betulinic Acid Enema Alleviates Colitis by Targeting Vitamin D Receptor to Protect the Intestinal Mucosal Barrier and Modulate Mucosa‐Associated Microbiota

Phytotherapy Research, EarlyView.
ABSTRACT Ulcerative colitis (UC) is a chronic inflammatory disease of the colon with limited effectiveness and safety of current drug therapies. Betulinic acid (BA) is a naturally occurring pentacyclic triterpenoid present in traditional Chinese medicines used clinically as retention enemas for UC, but its direct effects and mechanisms remain unclear ...
Lina Dong, Yuanxia Gao, Qian Li, Guangxin Chen, Dong Yang, Liping Zhao, Xiaojing Liu, Shumei Lin   +7 more
wiley   +1 more source

Using machine learning to predict clinical remission with exclusive enteral nutrition in pediatric Crohn disease. [PDF]

J Pediatr Gastroenterol Nutr
Suarez RGS, McClement DG, Vega R, Huynh HQ, Shaikh A, Otley A, Jacobson K, Sherlock M, Mack DR, Deslandres C, El-Matary W, Crowley E, deBruyn J, Walters T, Griffiths AM, Greiner R, Eytan Wine, Canadian Children IBD Network.   +17 more
europepmc   +1 more source

Nanobodies as next‐generation targeting platforms: From discovery technologies to translational biomedicine

VIEW, EarlyView.
Nanobodies, derived from the variable domains of camelid heavy‐chain‐only antibodies, have emerged as transformative biomedical tools due to their nanoscale size, exceptional stability, and unique capacity to recognize cryptic epitopes. This review provides a comprehensive overview of the field, outlining the structural and biochemical features of ...
Zhenrui Ye, Xianyang Li, Meixiao Zhan
wiley   +1 more source

A Therapeutic Tightrope: Managing Coexisting Crohn Disease and Systemic Lupus Erythematosus With Risankizumab. [PDF]

ACG Case Rep J
AlAwadhi H, Almutawa M, El Ouali S, Koutoubi Z, Memisoglu E, AlDuaij A, Namas R.   +6 more
europepmc   +1 more source

Lymphoproliferation Under Tumor Necrosis Factor Blockade: Parotid Mucosa-Associated Lymphoid Tissue Lymphoma in Crohn Disease With Sjögren Disease. [PDF]

ACR Open Rheumatol
Shen J, Tang M, Xu N, Liu Y, Li G.
europepmc   +1 more source